GlassScriptPhysician profile
Mallory Lynne Smith
NPI 1609334630
$1,875.56
in general payments reported to CMS, 2019-2025
22 companies · $68.18 in 2025
The $68.18 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.46 · 2023: $635 · 2024: $1,146 · 2025: $68.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,849.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $231.06 | 2024 | Rystiggo, Briviact, Nayzilam |
| Astrazeneca Pharmaceuticals LP | $165.96 | 2023-2024 | Andexxa |
| Eisai INC. | $162.49 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $149.61 | 2023-2024 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $144.36 | 2023-2024 | |
| Abbvie INC. | $132.65 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.97 | 2023-2024 | Hyqvia, Gammagard |
| Boston Scientific Corporation | $123.22 | 2023-2024 | Vercise |
| Teva Pharmaceuticals USA, INC. | $121.73 | 2024 | Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $114.04 | 2023-2024 | |
| Emd Serono, INC. | $90.20 | 2023-2024 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $59.39 | 2023-2024 | Ultomiris |
| Averitas Pharma INC. | $46.52 | 2023 | Qutenza |
| Lilly USA, LLC | $39.76 | 2024 | Amyvid, Kisunla |
| Otsuka America Pharmaceutical, INC. | $30.04 | 2023-2024 | Rexulti |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $26.46 | 2021 | |
| Livanova USA, INC. | $23.15 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Sumitomo Pharma America, INC. | $23.12 | 2023 | Aptiom |
| Curonix LLC | $18.82 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $16.77 | 2024 | Senza |
| Piramal Critical Care | $16.51 | 2023 | |
| Genentech USA, INC. | $13.73 | 2023 | Activase |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.